Medigen vaccines 結果共5筆

Premier Chen Chien-jen discusses the pricing process and confidentiality agreements surrounding Medigen vaccines, stating that negotiations with the Centers for Disease Control (CDC) are ongoing. As a publicly listed company, any decisions about publicizing the government contract require shareholders’ approval. Chen emphasizes the government’s belief in vaccination as the best measure against the pandemic. Medigen had positive results from phase one trials and clinical experiments, leading to phase two development. The World Health Organization (WHO) conducted unity trials with four other countries after being unable to proceed with phase three trials due to Taiwan’s low COVID-19 case statistics. Chen disputes rumors about a 30-year embargo on clinical results, calling it fake news and clarifying that all official documents have a preservation period. He also refutes accusations that over a thousand Medigen shareholders are members of the Democratic Progressive Party (DPP), calling them ＂imaginary numerical figures.＂ Chen hopes to disclose the information as soon as possible to maintain public trust, but it can only happen after negotiations and respecting existing confidentiality agreements.

Vice Presidential candidate Hsiao Bi-khim of the Democratic Progressive Party (DPP) vows to review and reflect on corruption allegations within the DPP government. This comes after her opponent, Kuomintang’s (KMT) Jaw Shaw-kong, accused the DPP of corruption during a policy presentation. Jaw raised concerns about the DPP obstructing Terry Gou’s acquisition of Pfizer-BioNTech vaccines and questioned the increase in the market value of Medigen Vaccine Biologics Corp. He advocated for the reinstatement of the Special Investigation Division to tackle corruption. Hsiao acknowledges mistakes within the party and emphasizes the need for self-review. She highlights the DPP’s commitment to reform and progressive policies, citing examples of marriage equality and energy transformation. Hsiao compares the government to a team in an international competition, emphasizing the importance of guidance and support for a unified nation.

Taichung Mayor Lu Shiow-yen emphasized transparency in flu vaccine information during the Municipal Administrative Meeting. The central government has purchased publicly-funded flu vaccines from four companies: Sanofi, Adimmune, TTY Biopharm, and Medigen. These vaccines will be available across all cities and counties.

The Taiwan FactCheck Center has clarified that MVC’s quadrivalent influenza vaccine is produced by the reputable South Korean pharmaceutical firm GC Biopharma, which has WHO qualification and is marketed in multiple countries. Additionally, the FactCheck Center noted that MVC’s method of vaccine production is not unprecedented, as other domestic manufacturers have also imported foreign vaccine stock solutions for local assembly.

The head of the Central Epidemic Command Center (CECC), Wang Pi-sheng, refuted claims on Tuesday (Nov. 1) that health authorities purchased Medigen vaccines above the market price.